Doctor John Ostrominski
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
Membership:
ESC Professional Member
HFA Member
Follow
Contributor content
Presentation
Cardiovascular-kidney-metabolic overlap and finerenone in heart failure: insights from the FINEARTS-HF Trial
Presentation
Finerenone with empagliflozin according to body mass index in chronic kidney disease and type 2 diabetes
Presentation
Simultaneous versus sequential initiation of CKM therapies: an indirect comparison of CONFIDENCE and FIDELITY
Presentation
Obesity and patient-reported health status in heart failure with preserved ejection fraction: a pooled analysis of 4 randomized clinical trials
Presentation
Presentation
Undiagnosed chronic kidney disease, outcomes, and finerenone in heart failure with preserved ejection fraction
Presentation
Presentation
Adiposity-related anthropometrics, cardiovascular outcomes, and finerenone in heart failure and chronic kidney disease with type 2 diabetes: a FINE-HEART analysis
Presentation
Presentation
